|
1
|
Upadhyay G, Gupta SP, Prakash O and Singh
MP: Pyrogallol-mediated toxicity and natural antioxidants: Triumphs
and pitfalls of preclinical findings and their translational
limitations. Chem Biol Interact. 183:333–340. 2010. View Article : Google Scholar
|
|
2
|
Kim SW, Han YW, Lee ST, Jeong HJ, Kim SH,
Kim IH, Lee SO, Kim DG, Kim SH, Kim SZ, et al: A superoxide anion
generator, pyrogallol, inhibits the growth of HeLa cells via cell
cycle arrest and apoptosis. Mol Carcinog. 47:114–125. 2008.
View Article : Google Scholar
|
|
3
|
Saeki K, Hayakawa S, Isemura M and Miyase
T: Importance of a pyrogallol-type structure in catechin compounds
for apoptosis-inducing activity. Phytochemistry. 53:391–394. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Park WH, Park MN, Han YH and Kim SW:
Pyrogallol inhibits the growth of gastric cancer SNU-484 cells via
induction of apoptosis. Int J Mol Med. 22:263–268. 2008.PubMed/NCBI
|
|
5
|
Park WH, Han YW, Kim SH and Kim SZ: A
superoxide anion generator, pyrogallol induces apoptosis in As4.1
cells through the depletion of intracellular GSH content. Mutat
Res. 619:81–92. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han YH, Kim SZ, Kim SH and Park WH:
Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the
changes of intracellular GSH levels rather than ROS levels. Lung
Cancer. 59:301–314. 2008. View Article : Google Scholar
|
|
7
|
Gonzalez C, Sanz-Alfayate G, Agapito MT,
Gomez-Niño A, Rocher A and Obeso A: Significance of ROS in oxygen
sensing in cell systems with sensitivity to physiological hypoxia.
Respir Physiol Neurobiol. 132:17–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baran CP, Zeigler MM, Tridandapani S and
Marsh CB: The role of ROS and RNS in regulating life and death of
blood monocytes. Curr Pharm Des. 10:855–866. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial ROS-induced ROS release: An update and review.
Biochim Biophys Acta. 1757:509–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: A comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wilcox CS: Reactive oxygen species: Roles
in blood pressure and kidney function. Curr Hypertens Rep.
4:160–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Marks PA: Thioredoxin in cancer - role of
histone deacetylase inhibitors. Semin Cancer Biol. 16:436–443.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han YH, Kim SH, Kim SZ and Park WH:
Pyrogallol inhibits the growth of human pulmonary adenocarcinoma
A549 cells by arresting cell cycle and triggering apoptosis. J
Biochem Mol Toxicol. 23:36–42. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han YH, Kim SZ, Kim SH and Park WH:
Pyrogallol inhibits the growth of human lung cancer Calu-6 cells
via arresting the cell cycle arrest. Toxicol In Vitro.
22:1605–1609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han YH, Kim SZ, Kim SH and Park WH:
Pyrogallol inhibits the growth of lung cancer Calu-6 cells via
caspase-dependent apoptosis. Chem Biol Interact. 177:107–114. 2009.
View Article : Google Scholar
|
|
16
|
Park WH and You BR: Antimycin A induces
death of the human pulmonary fibroblast cells via ROS increase and
GSH depletion. Int J Oncol. 48:813–820. 2016.
|
|
17
|
You BR, Kim SH and Park WH: Reactive
oxygen species, glutathione, and thioredoxin influence suberoyl
bishydroxamic acid-induced apoptosis in A549 lung cancer cells.
Tumour Biol. 36:3429–3439. 2015. View Article : Google Scholar
|
|
18
|
You BR, Shin HR, Han BR and Park WH: PX-12
induces apoptosis in Calu-6 cells in an oxidative stress-dependent
manner. Tumour Biol. 36:2087–2095. 2015. View Article : Google Scholar
|
|
19
|
Han YH, Kim SH, Kim SZ and Park WH:
Caspase inhibitor decreases apoptosis in pyrogallol-treated lung
cancer Calu-6 cells via the prevention of GSH depletion. Int J
Oncol. 33:1099–1105. 2008.PubMed/NCBI
|
|
20
|
Coutts AS and La Thangue N: The p53
response during DNA damage: Impact of transcriptional cofactors.
Biochem Soc Symp. 73:181–189. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ashkenazi A and Dixit VM: Death receptors:
Signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han YH and Park WH: Pyrogallol-induced
calf pulmonary arterial endothelial cell death via
caspase-dependent apoptosis and GSH depletion. Food Chem Toxicol.
48:558–563. 2010. View Article : Google Scholar
|
|
24
|
Oberley LW and Oberley TD: Role of
antioxidant enzymes in cell immortalization and transformation. Mol
Cell Biochem. 84:147–153. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park WH, Han YH, Kim SH and Kim SZ:
Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via
cell cycle arrest of G2 phase and apoptosis. Toxicology.
235:130–139. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang CJ, Wang CS, Hung JY, Huang HW, Chia
YC, Wang PH, Weng CF and Huang MS: Pyrogallol induces G2-M arrest
in human lung cancer cells and inhibits tumor growth in an animal
model. Lung Cancer. 66:162–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SJ, Miyoshi Y, Taguchi T, Tamaki Y,
Nakamura H, Yodoi J, Kato K and Noguchi S: High thioredoxin
expression is associated with resistance to docetaxel in primary
breast cancer. Clin Cancer Res. 11:8425–8430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han YH, Kim SZ, Kim SH and Park WH:
Pyrogallol as a glutathione depletor induces apoptosis in HeLa
cells. Int J Mol Med. 21:721–730. 2008.PubMed/NCBI
|
|
29
|
Han YH, Moon HJ, You BR, Kim SZ, Kim SH
and Park WH: Pyrogallol-induced endothelial cell death is related
to GSH depletion rather than ROS level changes. Oncol Rep.
23:287–292. 2010.
|
